Sign in
4

Changes in Ownership

Aquestive Therapeutics, Inc. Filed Acc 0001214659-23-006558

Options or other derivatives

  • Chief Innovation/Tech Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Schobel Alexander Mark · Chief Innovation/Tech Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-05 Grant or award : show line 1 in the form Performance Stock Units +50,000 50,000 D
Loading xslF345X04/marketforms-61240.xml…